{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T22:48:26Z","timestamp":1791931706433,"version":"4.3.4"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,4,30]],"date-time":"2020-04-30T00:00:00Z","timestamp":1588204800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2020,4,30]],"date-time":"2020-04-30T00:00:00Z","timestamp":1588204800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"EU FP7 INMIND Project spiepr132","award":["no.spiepr146 278850"],"award-info":[{"award-number":["no.spiepr146 278850"]}]},{"name":"IVASCOMAR project","award":["no.spiepr146 CTN01_00177_165430"],"award-info":[{"award-number":["no.spiepr146 CTN01_00177_165430"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Alz Res Therapy"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n<jats:title>Background<\/jats:title>\n<jats:p>Early-onset Alzheimer\u2019s disease (EOAD) is characterized by young age of onset (&lt;\u200965\u2009years), severe neurodegeneration, and rapid disease progression, thus differing significantly from typical late-onset Alzheimer\u2019s disease. Growing evidence suggests a primary role of neuroinflammation in AD pathogenesis. However, the role of microglia activation in EOAD remains a poorly explored field. Investigating microglial activation and its influence on the development of synaptic dysfunction and neuronal loss in EOAD may contribute to the understanding of its pathophysiology and to subject selection in clinical trials. In our study, we aimed to assess the amount of neuroinflammation and neurodegeneration and their relationship in EOAD patients, through positron emission tomography (PET) measures of microglia activation and brain metabolic changes.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Methods<\/jats:title>\n<jats:p>We prospectively enrolled 12 EOAD patients, classified according to standard criteria, who underwent standard neurological and neuropsychological evaluation, CSF analysis, brain MRI, and both [<jats:sup>18<\/jats:sup>F]-FDG PET and [<jats:sup>11<\/jats:sup>C]-(R)-PK11195 PET. Healthy controls databases were used for statistical comparison. [<jats:sup>18<\/jats:sup>F]-FDG PET brain metabolism in single subjects and as a group was assessed by an optimized SPM voxel-wise single-subject method. [<jats:sup>11<\/jats:sup>C]-PK11195 PET binding potentials were obtained using reference regions selected with an optimized clustering procedure followed by a parametric analysis. We performed a topographic interaction analysis and correlation analysis in AD-signature metabolic dysfunctional regions and regions of microglia activation. A network connectivity analysis was performed using the interaction regions of hypometabolism and [<jats:sup>11<\/jats:sup>C]-PK11195 PET BP increases.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Results<\/jats:title>\n<jats:p>EOAD patients showed a significant and extended microglia activation, as [<jats:sup>11<\/jats:sup>C]-PK11195 PET binding potential increases, and hypometabolism in typical AD-signature brain regions, i.e., temporo-parietal cortex, with additional variable frontal and occipital hypometabolism in the EOAD variants. There was a spatial concordance in the interaction areas and significant correlations between the two biological changes. The network analysis showed a disruption of frontal connectivity induced by the metabolic\/microglia effects.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Conclusion<\/jats:title>\n<jats:p>The severe microglia activation characterizing EOAD and contributing to neurodegeneration may be a marker of rapid disease progression. The coupling between brain glucose hypometabolism and local immune response in AD-signature regions supports their biological interaction.<\/jats:p>\n<\/jats:sec>","DOI":"10.1186\/s13195-020-00619-0","type":"journal-article","created":{"date-parts":[[2020,4,30]],"date-time":"2020-04-30T12:02:45Z","timestamp":1588248165000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":104,"title":["The combined effects of microglia activation and brain glucose hypometabolism in early-onset Alzheimer\u2019s disease"],"prefix":"10.1186","volume":"12","author":[{"given":"Giacomo","family":"Tondo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonardo","family":"Iaccarino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia Paola","family":"Caminiti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Presotto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Santangelo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandro","family":"Iannaccone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Magnani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9784-292X","authenticated-orcid":false,"given":"Daniela","family":"Perani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,4,30]]},"reference":[{"key":"619_CR1","doi-asserted-by":"publisher","first-page":"15056","DOI":"10.1038\/nrdp.2015.56","volume":"1","author":"CL Masters","year":"2015","unstructured":"Masters CL, Bateman R, Blennow K, Rowe CC, Sperling RA, Cummings JL. Alzheimer\u2019s disease. Nat Rev Dis Prim. 2015;1:15056. https:\/\/doi.org\/10.1038\/nrdp.2015.56.","journal-title":"Nat Rev Dis Prim"},{"issue":"6301","key":"619_CR2","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1126\/science.aag2590","volume":"353","author":"RM Ransohoff","year":"2016","unstructured":"Ransohoff RM. How neuroinflammation contributes to neurodegeneration. Science (80- ). 2016;353(6301):777\u201383.","journal-title":"Science (80- )"},{"issue":"10","key":"619_CR3","doi-asserted-by":"crossref","first-page":"8071","DOI":"10.1007\/s12035-016-0297-1","volume":"54","author":"M Sochocka","year":"2017","unstructured":"Sochocka M, Diniz BS, Leszek J. Inflammatory response in the CNS: friend or foe? Mol Neurobiol. 2017;54(10):8071\u201389.","journal-title":"Mol Neurobiol"},{"issue":"5","key":"619_CR4","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/S1474-4422(16)00062-4","volume":"15","author":"B Winblad","year":"2016","unstructured":"Winblad B, Amouyel P, Andrieu S, et al. Defeating Alzheimer\u2019s disease and other dementias: a priority for European science and society. Lancet Neurol. 2016;15(5):455\u2013532.","journal-title":"Lancet Neurol"},{"issue":"7","key":"619_CR5","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1177\/1533317512459798","volume":"27","author":"NC Kaiser","year":"2012","unstructured":"Kaiser NC, Melrose RJ, Liu C, et al. Neuropsychological and neuroimaging markers in early versus late-onset Alzheimer\u2019s disease. Am J Alzheimer\u2019s Dis Other Dementias\u00ae. 2012;27(7):520\u20139.","journal-title":"Am J Alzheimer\u2019s Dis Other Dementias\u00ae."},{"issue":"1","key":"619_CR6","doi-asserted-by":"crossref","first-page":"101","DOI":"10.3233\/JAD-2012-111934","volume":"30","author":"LL Smits","year":"2012","unstructured":"Smits LL, Pijnenburg YAL, Koedam ELGE, et al. Early onset Alzheimer\u2019s disease is associated with a distinct neuropsychological profile. J Alzheimers Dis. 2012;30(1):101\u20138.","journal-title":"J Alzheimers Dis"},{"key":"619_CR7","first-page":"81","volume":"3","author":"F S\u00e1","year":"2012","unstructured":"S\u00e1 F, Pinto P, Cunha C, et al. Differences between early and late-onset Alzheimer\u2019s disease in neuropsychological tests. Front Neurol. 2012;3:81.","journal-title":"Front Neurol"},{"issue":"4","key":"619_CR8","first-page":"300","volume":"2","author":"PK Panegyres","year":"2013","unstructured":"Panegyres PK, Chen H-Y. Differences between early and late onset Alzheimer\u2019s disease. Am J Neurodegener Dis. 2013;2(4):300.","journal-title":"Am J Neurodegener Dis"},{"issue":"12","key":"619_CR9","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1017\/S1041610214001173","volume":"26","author":"K Stanley","year":"2014","unstructured":"Stanley K, Walker Z. Do patients with young onset Alzheimer\u2019s disease deteriorate faster than those with late onset Alzheimer\u2019s disease? A review of the literature. Int Psychogeriatrics. 2014;26(12):1945\u201353.","journal-title":"Int Psychogeriatrics"},{"issue":"1","key":"619_CR10","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1186\/s13195-017-0294-2","volume":"9","author":"C Wattmo","year":"2017","unstructured":"Wattmo C, Wallin \u00c5K. Early-versus late-onset Alzheimer\u2019s disease in clinical practice: cognitive and global outcomes over 3 years. Alzheimers Res Ther. 2017;9(1):70.","journal-title":"Alzheimers Res Ther"},{"issue":"1","key":"619_CR11","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1212\/CON.0000000000000687","volume":"25","author":"MF Mendez","year":"2019","unstructured":"Mendez MF. Early-onset Alzheimer disease and its variants. Contin Lifelong Learn Neurol. 2019;25(1):34\u201351.","journal-title":"Contin Lifelong Learn Neurol"},{"issue":"20","key":"619_CR12","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1212\/WNL.0b013e31821a44dd","volume":"76","author":"M Balasa","year":"2011","unstructured":"Balasa M, Gelpi E, Antonell A, et al. Clinical features and APOE genotype of pathologically proven early-onset Alzheimer disease. Neurology. 2011;76(20):1720\u20135.","journal-title":"Neurology."},{"issue":"3","key":"619_CR13","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1046\/j.1365-2990.2002.00385.x","volume":"28","author":"EH Bigio","year":"2002","unstructured":"Bigio EH, Hynan LS, Sontag E, Satumtira S, White CL III. Synapse loss is greater in presenile than senile onset Alzheimer disease: implications for the cognitive reserve hypothesis. Neuropathol Appl Neurobiol. 2002;28(3):218\u201327.","journal-title":"Neuropathol Appl Neurobiol"},{"issue":"5","key":"619_CR14","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1007\/s00415-015-7698-3","volume":"262","author":"A Palas\u00ed","year":"2015","unstructured":"Palas\u00ed A, Guti\u00e9rrez-Iglesias B, Alegret M, et al. Differentiated clinical presentation of early and late-onset Alzheimer\u2019s disease: is 65 years of age providing a reliable threshold? J Neurol. 2015;262(5):1238\u201346.","journal-title":"J Neurol"},{"issue":"1","key":"619_CR15","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1136\/jnnp.2003.029876","volume":"76","author":"GB Frisoni","year":"2005","unstructured":"Frisoni GB, Testa C, Sabattoli F, Beltramello A, Soininen H, Laakso MP. Structural correlates of early and late onset Alzheimer\u2019s disease: voxel based morphometric study. J Neurol Neurosurg Psychiatry. 2005;76(1):112\u20134.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"1","key":"619_CR16","doi-asserted-by":"crossref","first-page":"183","DOI":"10.3233\/JAD-160682","volume":"55","author":"C Cerami","year":"2017","unstructured":"Cerami C, Dodich A, Greco L, et al. The role of single-subject brain metabolic patterns in the early differential diagnosis of primary progressive aphasias and in prediction of progression to dementia. J Alzheimers Dis. 2017;55(1):183\u201397.","journal-title":"J Alzheimers Dis"},{"key":"619_CR17","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1016\/j.nicl.2014.10.009","volume":"6","author":"D Perani","year":"2014","unstructured":"Perani D, Della Rosa PA, Cerami C, et al. Validation of an optimized SPM procedure for FDG-PET in dementia diagnosis in a clinical setting. NeuroImage Clin. 2014;6:445\u201354. https:\/\/doi.org\/10.1016\/j.nicl.2014.10.009.","journal-title":"NeuroImage Clin"},{"issue":"7","key":"619_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/j.jalz.2016.06.1041","volume":"12","author":"M Vanhoutte","year":"2016","unstructured":"Vanhoutte M, Lopes R, Maureille A, et al. Hypometabolism patterns using FDG-PET in typical and atypical sporadic forms of early-onset Alzheimer\u2019s disease. Alzheimers Dement. 2016;12(7):P532. https:\/\/doi.org\/10.1016\/j.jalz.2016.06.1041.","journal-title":"Alzheimers Dement"},{"key":"619_CR19","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.nicl.2018.01.019","volume":"18","author":"SP Caminiti","year":"2018","unstructured":"Caminiti SP, Ballarini T, Sala A, et al. FDG-PET and CSF biomarker accuracy in prediction of conversion to different dementias in a large multicentre MCI cohort. NeuroImage Clin. 2018;18:167\u201377.","journal-title":"NeuroImage Clin."},{"issue":"2","key":"619_CR20","doi-asserted-by":"crossref","first-page":"603","DOI":"10.3233\/JAD-170158","volume":"59","author":"L Iaccarino","year":"2017","unstructured":"Iaccarino L, Chiotis K, Alongi P, et al. A cross-validation of FDG-and amyloid-PET biomarkers in mild cognitive impairment for the risk prediction to dementia due to Alzheimer\u2019s disease in a clinical setting. J Alzheimers Dis. 2017;59(2):603\u201314.","journal-title":"J Alzheimers Dis"},{"issue":"3","key":"619_CR21","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1007\/s00259-015-3170-y","volume":"43","author":"D Perani","year":"2016","unstructured":"Perani D, Cerami C, Caminiti SP, et al. Cross-validation of biomarkers for the early differential diagnosis and prognosis of dementia in a clinical setting. Eur J Nucl Med Mol Imaging. 2016;43(3):499\u2013508.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"619_CR22","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.nicl.2014.12.004","volume":"7","author":"C Cerami","year":"2015","unstructured":"Cerami C, Della Rosa PA, Magnani G, et al. Brain metabolic maps in mild cognitive impairment predict heterogeneity of progression to dementia. NeuroImage Clin. 2015;7:187\u201394.","journal-title":"NeuroImage Clin."},{"issue":"2","key":"619_CR23","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1093\/brain\/awp326","volume":"133","author":"GD Rabinovici","year":"2010","unstructured":"Rabinovici GD, Furst AJ, Alkalay A, et al. Increased metabolic vulnerability in early-onset Alzheimer\u2019s disease is not related to amyloid burden. Brain. 2010;133(2):512\u201328.","journal-title":"Brain."},{"issue":"1","key":"619_CR24","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1159\/000441776","volume":"6","author":"A Chiaravalloti","year":"2016","unstructured":"Chiaravalloti A, Koch G, Toniolo S, et al. Comparison between early-onset and late-onset Alzheimer\u2019s disease patients with amnestic presentation: CSF and 18F-FDG PET study. Dement Geriatr Cogn Dis Extra. 2016;6(1):108\u201319.","journal-title":"Dement Geriatr Cogn Dis Extra"},{"issue":"8","key":"619_CR25","doi-asserted-by":"crossref","first-page":"1790","DOI":"10.1093\/brain\/awh539","volume":"128","author":"EJ Kim","year":"2005","unstructured":"Kim EJ, Cho SS, Jeong Y, et al. Glucose metabolism in early onset versus late onset Alzheimer\u2019s disease: an SPM analysis of 120 patients. Brain. 2005;128(8):1790\u2013801.","journal-title":"Brain."},{"key":"619_CR26","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.neurobiolaging.2017.08.009","volume":"59","author":"M Vanhoutte","year":"2017","unstructured":"Vanhoutte M, Semah F, Sillaire AR, et al. 18F-FDG PET hypometabolism patterns reflect clinical heterogeneity in sporadic forms of early-onset Alzheimer\u2019s disease. Neurobiol Aging. 2017;59:184\u201396.","journal-title":"Neurobiol Aging"},{"issue":"12","key":"619_CR27","doi-asserted-by":"crossref","first-page":"4234","DOI":"10.1002\/hbm.23305","volume":"37","author":"T Ballarini","year":"2016","unstructured":"Ballarini T, Iaccarino L, Magnani G, et al. Neuropsychiatric subsyndromes and brain metabolic network dysfunctions in early onset Alzheimer\u2019s disease. Hum Brain Mapp. 2016;37(12):4234\u201347.","journal-title":"Hum Brain Mapp"},{"key":"619_CR28","doi-asserted-by":"crossref","first-page":"617","DOI":"10.3389\/fnins.2019.00617","volume":"13","author":"A Sala","year":"2019","unstructured":"Sala A, Perani D. Brain molecular connectivity in neurodegenerative diseases: recent advances and new perspectives using positron emission tomography. Front Neurosci. 2019;13:617.","journal-title":"Front Neurosci"},{"issue":"6","key":"619_CR29","doi-asserted-by":"crossref","first-page":"2027","DOI":"10.1002\/hbm.22753","volume":"36","author":"S Passow","year":"2015","unstructured":"Passow S, Specht K, Adamsen TC, et al. Default-mode network functional connectivity is closely related to metabolic activity. Hum Brain Mapp. 2015;36(6):2027\u201338.","journal-title":"Hum Brain Mapp"},{"issue":"4","key":"619_CR30","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1038\/jcbfm.1984.73","volume":"4","author":"B Horwitz","year":"1984","unstructured":"Horwitz B, Duara R, Rapoport SI. Intercorrelations of glucose metabolic rates between brain regions: application to healthy males in a state of reduced sensory input. J Cereb Blood Flow Metab. 1984;4(4):484\u201399.","journal-title":"J Cereb Blood Flow Metab"},{"issue":"11","key":"619_CR31","doi-asserted-by":"crossref","first-page":"2533","DOI":"10.1016\/j.neurobiolaging.2012.01.005","volume":"33","author":"S Morbelli","year":"2012","unstructured":"Morbelli S, Drzezga A, Perneczky R, et al. Resting metabolic connectivity in prodromal Alzheimer\u2019s disease. A European Alzheimer Disease Consortium (EADC) project. Neurobiol Aging. 2012;33(11):2533\u201350.","journal-title":"Neurobiol Aging"},{"issue":"8","key":"619_CR32","doi-asserted-by":"crossref","first-page":"4212","DOI":"10.1002\/hbm.23659","volume":"38","author":"M Malpetti","year":"2017","unstructured":"Malpetti M, Ballarini T, Presotto L, et al. Gender differences in healthy aging and Alzheimer\u2019s dementia: a 18F-FDG-PET study of brain and cognitive reserve. Hum Brain Mapp. 2017;38(8):4212\u201327.","journal-title":"Hum Brain Mapp"},{"key":"619_CR33","doi-asserted-by":"crossref","first-page":"159","DOI":"10.3389\/fnagi.2016.00159","volume":"8","author":"J Chung","year":"2016","unstructured":"Chung J, Yoo K, Kim E, Na DL, Jeong Y. Glucose metabolic brain networks in early-onset vs late-onset Alzheimer\u2019s disease. Front Aging Neurosci. 2016;8:159.","journal-title":"Front Aging Neurosci"},{"issue":"8","key":"619_CR34","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/j.tips.2006.06.005","volume":"27","author":"V Papadopoulos","year":"2006","unstructured":"Papadopoulos V, Baraldi M, Guilarte TR, et al. Translocator protein (18 kDa): new nomenclature for the peripheral-type benzodiazepine receptor based on its structure and molecular function. Trends Pharmacol Sci. 2006;27(8):402\u20139.","journal-title":"Trends Pharmacol Sci"},{"issue":"2","key":"619_CR35","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1111\/j.1365-2567.2009.03225.x","volume":"129","author":"S Amor","year":"2010","unstructured":"Amor S, Puentes F, Baker D, Van Der Valk P. Inflammation in neurodegenerative diseases. Immunology. 2010;129(2):154\u201369.","journal-title":"Immunology."},{"issue":"5","key":"619_CR36","doi-asserted-by":"crossref","first-page":"993","DOI":"10.3390\/ijms18050993","volume":"18","author":"C Cerami","year":"2017","unstructured":"Cerami C, Iaccarino L, Perani D. Molecular imaging of neuroinflammation in neurodegenerative dementias: the role of in vivo PET imaging. Int J Mol Sci. 2017;18(5):993.","journal-title":"Int J Mol Sci"},{"issue":"12","key":"619_CR37","doi-asserted-by":"crossref","first-page":"3685","DOI":"10.1093\/brain\/awv288","volume":"138","author":"Z Fan","year":"2015","unstructured":"Fan Z, Okello AA, Brooks DJ, Edison P. Longitudinal influence of microglial activation and amyloid on neuronal function in Alzheimer\u2019s disease. Brain. 2015;138(12):3685\u201398.","journal-title":"Brain."},{"issue":"6","key":"619_CR38","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1016\/j.jalz.2014.06.016","volume":"11","author":"Z Fan","year":"2015","unstructured":"Fan Z, Aman Y, Ahmed I, et al. Influence of microglial activation on neuronal function in Alzheimer\u2019s and Parkinson\u2019s disease dementia. Alzheimers Dement. 2015;11(6):608\u201321.","journal-title":"Alzheimers Dement"},{"issue":"7","key":"619_CR39","doi-asserted-by":"crossref","first-page":"2228","DOI":"10.1093\/brain\/awt145","volume":"136","author":"WC Kreisl","year":"2013","unstructured":"Kreisl WC, Lyoo CH, McGwier M, et al. In vivo radioligand binding to translocator protein correlates with severity of Alzheimer\u2019s disease. Brain. 2013;136(7):2228\u201338.","journal-title":"Brain."},{"key":"619_CR40","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.neurobiolaging.2016.04.011","volume":"44","author":"WC Kreisl","year":"2016","unstructured":"Kreisl WC, Lyoo CH, Liow J, et al. 11C-PBR28 binding to translocator protein increases with progression of Alzheimer\u2019s disease. Neurobiol Aging. 2016;44:53\u201361.","journal-title":"Neurobiol Aging"},{"issue":"4","key":"619_CR41","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1021\/jm001004h","volume":"44","author":"M Matarrese","year":"2001","unstructured":"Matarrese M, Moresco RM, Cappelli A, et al. Labeling and evaluation of N-[11C] methylated quinoline-2-carboxamides as potential radioligands for visualization of peripheral benzodiazepine receptors. J Med Chem. 2001;44(4):579\u201385.","journal-title":"J Med Chem"},{"issue":"4","key":"619_CR42","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1007\/s12021-014-9235-4","volume":"12","author":"PA Della Rosa","year":"2014","unstructured":"Della Rosa PA, Cerami C, Gallivanone F, et al. A standardized [18 F]-FDG-PET template for spatial normalization in statistical parametric mapping of dementia. Neuroinformatics. 2014;12(4):575\u201393.","journal-title":"Neuroinformatics."},{"issue":"4","key":"619_CR43","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1006\/nimg.1997.0303","volume":"6","author":"RN Gunn","year":"1997","unstructured":"Gunn RN, Lammertsma AA, Hume SP, Cunningham VJ. Parametric imaging of ligand-receptor binding in PET using a simplified reference region model. Neuroimage. 1997;6(4):279\u201387.","journal-title":"Neuroimage."},{"key":"619_CR44","doi-asserted-by":"crossref","unstructured":"Presotto L, Iaccarino L, Bettinardi V, Gianolli L, Perani D. An automated clustering algorithm for reference region extraction of brain 11 C-PK11195 studies. In: 2015 IEEE nuclear science symposium and medical imaging conference (NSS\/MIC). IEEE; 2015:1\u20133.","DOI":"10.1109\/NSSMIC.2015.7582180"},{"issue":"1","key":"619_CR45","first-page":"158","volume":"48","author":"FE Turkheimer","year":"2007","unstructured":"Turkheimer FE, Edison P, Pavese N, et al. Reference and target region modeling of [11C]-(R)-PK11195 brain studies. J Nucl Med. 2007;48(1):158\u201367.","journal-title":"J Nucl Med"},{"key":"619_CR46","doi-asserted-by":"publisher","unstructured":"Passamonti L, Tsvetanov KA, Jones PS, et al. Neuroinflammation and functional connectivity in Alzheimer\u2019s disease: interactive influences on cognitive performance. J Neurosci. 2019. doi: https:\/\/doi.org\/10.1523\/JNEUROSCI.2574-18.2019.","DOI":"10.1523\/JNEUROSCI.2574-18.2019"},{"issue":"9","key":"619_CR47","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1007\/s00259-008-0808-z","volume":"35","author":"DS Lee","year":"2008","unstructured":"Lee DS, Kang H, Kim H, et al. Metabolic connectivity by interregional correlation analysis using statistical parametric mapping (SPM) and FDG brain PET; methodological development and patterns of metabolic connectivity in adults. Eur J Nucl Med Mol Imaging. 2008;35(9):1681\u201391.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"3","key":"619_CR48","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.jalz.2011.03.005","volume":"7","author":"GM McKhann","year":"2011","unstructured":"McKhann GM, Knopman DS, Chertkow H, et al. The diagnosis of dementia due to Alzheimer\u2019s disease: recommendations from the National Institute on Aging-Alzheimer\u2019s Association workgroups on diagnostic guidelines for Alzheimer\u2019s disease. Alzheimers Dement. 2011;7(3):263\u20139.","journal-title":"Alzheimers Dement"},{"issue":"6","key":"619_CR49","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1016\/S1474-4422(14)70090-0","volume":"13","author":"B Dubois","year":"2014","unstructured":"Dubois B, Feldman HH, Jacova C, et al. Advancing research diagnostic criteria for Alzheimer\u2019s disease: the IWG-2 criteria. Lancet Neurol. 2014;13(6):614\u201329.","journal-title":"Lancet Neurol"},{"issue":"9280","key":"619_CR50","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/S0140-6736(01)05625-2","volume":"358","author":"A Cagnin","year":"2001","unstructured":"Cagnin A, Brooks DJ, Kennedy AM, et al. In-vivo measurement of activated microglia in dementia. Lancet. 2001;358(9280):461\u20137.","journal-title":"Lancet."},{"issue":"3","key":"619_CR51","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.nbd.2008.08.001","volume":"32","author":"P Edison","year":"2008","unstructured":"Edison P, Archer HA, Gerhard A, et al. Microglia, amyloid, and cognition in Alzheimer\u2019s disease: an [11C](R) PK11195-PET and [11C] PIB-PET study. Neurobiol Dis. 2008;32(3):412\u20139.","journal-title":"Neurobiol Dis"},{"issue":"2","key":"619_CR52","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1007\/s00259-010-1612-0","volume":"38","author":"M Yokokura","year":"2011","unstructured":"Yokokura M, Mori N, Yagi S, et al. In vivo changes in microglial activation and amyloid deposits in brain regions with hypometabolism in Alzheimer\u2019s disease. Eur J Nucl Med Mol Imaging. 2011;38(2):343\u201351.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"619_CR53","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.neurobiolaging.2016.12.006","volume":"51","author":"WC Kreisl","year":"2017","unstructured":"Kreisl WC, Lyoo CH, Liow J-S, et al. Distinct patterns of increased translocator protein in posterior cortical atrophy and amnestic Alzheimer\u2019s disease. Neurobiol Aging. 2017;51:132\u201340.","journal-title":"Neurobiol Aging"},{"issue":"8","key":"619_CR54","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1007\/s00702-010-0433-4","volume":"117","author":"CYD Lee","year":"2010","unstructured":"Lee CYD, Landreth GE. The role of microglia in amyloid clearance from the AD brain. J Neural Transm. 2010;117(8):949\u201360.","journal-title":"J Neural Transm"},{"issue":"4","key":"619_CR55","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/S1474-4422(15)70016-5","volume":"14","author":"MT Heneka","year":"2015","unstructured":"Heneka MT, Carson MJ, El Khoury J, et al. Neuroinflammation in Alzheimer\u2019s disease. Lancet Neurol. 2015;14(4):388\u2013405.","journal-title":"Lancet Neurol"},{"issue":"8","key":"619_CR56","doi-asserted-by":"crossref","first-page":"1939","DOI":"10.1016\/j.celrep.2018.07.072","volume":"24","author":"J Brelstaff","year":"2018","unstructured":"Brelstaff J, Tolkovsky AM, Ghetti B, Goedert M, Spillantini MG. Living neurons with tau filaments aberrantly expose phosphatidylserine and are phagocytosed by microglia. Cell Rep. 2018;24(8):1939\u201348.","journal-title":"Cell Rep"}],"container-title":["Alzheimer's Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13195-020-00619-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13195-020-00619-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13195-020-00619-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,29]],"date-time":"2021-04-29T23:22:27Z","timestamp":1619738547000},"score":1,"resource":{"primary":{"URL":"https:\/\/alzres.biomedcentral.com\/articles\/10.1186\/s13195-020-00619-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4,30]]},"references-count":56,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["619"],"URL":"https:\/\/doi.org\/10.1186\/s13195-020-00619-0","relation":{},"ISSN":["1758-9193"],"issn-type":[{"value":"1758-9193","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,4,30]]},"assertion":[{"value":"31 August 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 April 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 April 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was approved by the San Raffaele Hospital Ethical Committees (ref num 72\/2012.int). Informed consent was obtained from each subject or relatives; the protocols conformed to the Ethical standards of the declaration of Helsinki for protection of human subjects.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All patients and\/or caregivers gave written informed consent to the study\/data treatment for scientific purposes, including publications. The informed consents are available from the corresponding author on request. All the reported data are anonymized, and no patient can be identified by the reported data.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"50"}}